The global genital herpes treatment market is expected to grow at a CAGR of 5.2% from 2023 to 2033. Market valuation will ...

Over 200 million individuals aged 15–49 likely experienced at least one symptomatic outbreak in 2020, highlighting the urgent ...

This Sexually Transmitted Infection Question Day (January 14) we speak to a GP about one of the most common STIs.

Learn about herpes transmission prevention symptoms and modern treatment options to better manage HSV-1 and HSV-2 infections today.

Lab-grown mini-brains help scientists explore how concussions reactivate latent viral infections, triggering molecular ...

Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

Whereas HSV-1 latency is found only in cranial nerve ganglia, HSV-2 becomes latent in lumbrosacral ganglia. The treatment for HSV-2 encephalitis is the same as for HSV-1 (see above). HSV ...

This highlights the widespread nature of genital HSV infections and the resulting GUD burden. The study calls for new prevention and treatment strategies, such as vaccines, to reduce these ...

Prophylactic valaciclovir was effective and prevented herpes zoster in patients with systemic lupus erythematosus receiving ...

the risk of opportunistic infections in patients with IBD who receive immunosuppressive therapy has so far only been studied retrospectively. The increased incidence of herpes flares and ...

Genital herpes, an STI caused by herpes simplex virus (HSV), is prevalent and commonly transmitted through sexual contact.